These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9052763)
1. Mechanism of increased sensitivity to etoposide in a mitomycin C-resistant human bladder cancer cell line. Xia H; Bleicher RJ; Gupta V; Zaren HA; Singh SV Int J Cancer; 1997 Mar; 70(5):606-11. PubMed ID: 9052763 [TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of a mitomycin C-resistant human bladder cancer cell line. Singh SV; Scalamogna D; Xia H; O'Toole S; Roy D; Emerson EO; Gupta V; Zaren HA Int J Cancer; 1996 Mar; 65(6):852-7. PubMed ID: 8631603 [TBL] [Abstract][Full Text] [Related]
3. Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line. Bleicher RJ; Xia H; Zaren HA; Singh SV Cancer Lett; 2000 Mar; 150(2):129-35. PubMed ID: 10704734 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a human bladder cancer cell line selected for resistance to mitomycin C. Xu BH; Gupta V; Singh SV Int J Cancer; 1994 Sep; 58(5):686-92. PubMed ID: 8077054 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line. Singh SV; Xu BH; Jani JP; Emerson EO; Backes MG; Rihn C; Scalamogna D; Stemmler N; Specht S; Blanock K Int J Cancer; 1995 May; 61(3):431-6. PubMed ID: 7729958 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a BMS-181174-resistant human bladder cancer cell line. Xia H; Bleicher RJ; Hu X; Srivastava SK; Gupta V; Zaren HA; Singh SV Br J Cancer; 1997; 76(4):461-6. PubMed ID: 9275022 [TBL] [Abstract][Full Text] [Related]
7. Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue. Xu BH; Gupta V; Singh SV Br J Cancer; 1994 Feb; 69(2):242-6. PubMed ID: 8297721 [TBL] [Abstract][Full Text] [Related]
8. [Mechanism of resistance to mitomycin C in a human bladder cancer cell line]. Xu B; Sun Y; Singh SV Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):343-6. PubMed ID: 8697971 [TBL] [Abstract][Full Text] [Related]
9. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
10. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Schneider E; Horton JK; Yang CH; Nakagawa M; Cowan KH Cancer Res; 1994 Jan; 54(1):152-8. PubMed ID: 7903202 [TBL] [Abstract][Full Text] [Related]
11. Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype. Matsumoto Y; Takano H; Fojo T Cancer Res; 1997 Nov; 57(22):5086-92. PubMed ID: 9371507 [TBL] [Abstract][Full Text] [Related]
12. In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance. Taki T; Ohnishi T; Arita N; Hiraga S; Hayakawa T J Neurooncol; 1998 Jan; 36(1):41-53. PubMed ID: 9525824 [TBL] [Abstract][Full Text] [Related]
13. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
14. Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line. Matsumoto Y; Kunishio K; Nagao S J Neurooncol; 1999; 45(1):37-46. PubMed ID: 10728908 [TBL] [Abstract][Full Text] [Related]
15. Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene. Lorico A; Rappa G; Srimatkandada S; Catapano CV; Fernandes DJ; Germino JF; Sartorelli AC Cancer Res; 1995 Oct; 55(19):4352-60. PubMed ID: 7671247 [TBL] [Abstract][Full Text] [Related]
16. Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide. Herzog CE; Zwelling LA; McWatters A; Kleinerman ES Clin Cancer Res; 1995 Nov; 1(11):1391-7. PubMed ID: 9815936 [TBL] [Abstract][Full Text] [Related]
17. Hypophosphorylation of topoisomerase IIalpha in etoposide (VP-16)-resistant human carcinoma cell lines associated with carboxy-terminal truncation. Matsumoto Y; Takano H; Kunishio K; Nagao S; Fojo T Jpn J Cancer Res; 2001 Jul; 92(7):799-805. PubMed ID: 11473732 [TBL] [Abstract][Full Text] [Related]
18. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta. Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C. Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243 [TBL] [Abstract][Full Text] [Related]
20. Investigation of sequential mitomycin C and photodynamic therapy in a mitomycin-resistant bladder cancer cell-line model. French AJ; Datta SN; Allman R; Matthews PN BJU Int; 2004 Jan; 93(1):156-61. PubMed ID: 14678389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]